Core value dossiers for medical technologies
Essential tool to support market access and marketing efforts through the lifecycle of the product
White Paper: Evidence Requirements for Interventional Procedures Program at NICE in the United Kingdom
Get insights from MTRC White Papers to advance your understanding of European market access for medical procedures
Recent news and posts
Sustainability Publication Digest: Environmental sustainability in health technology assessment: an analysis of the activities of Canada's Drug Agency and the England's NICE
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest.
In a recent publication, Parker et al. explored how Canada’s Drug Agency (CDA) and England’s NICE have started to incorporate environmental sustainability into health technology assessments (HTAs). Reviewing 30 documents published between 2015 and 2024, the authors found growing awareness within both agencies but limited practical implementation. CDA emphasized a full lifecycle approach, while NICE concentrated on reducing carbon emissions during technology use. Both organizations began to consider the environmental impact of medical devices, while work on medicines remained largely absent. Despite progress, no HTAs had yet integrated environmental data, underscoring the need for further framework development.
Access the full-text article here.